metformin has been researched along with galactose in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 8 (47.06) | 2.80 |
| Authors | Studies |
|---|---|
| Adikwu, MU; Takada, K; Yoshikawa, Y | 1 |
| Attia, A; El-Shenawy, S; Gomaa, N; Hassan, A; Hegazy, R; Kenawy, S; Zaki, H | 1 |
| Huang, W; Li, S; Li, Y; Ma, L; Niu, H; Wei, Z; Xin, G; Xing, Z; Xu, Y; Zeng, Z | 1 |
| Allahtavakoli, M; Fatemi, I; Hakimizadeh, E; Heydari, S; Kaeidi, A; Khaluoi, A; Shamsizadeh, A | 1 |
| Askari, VR; Mousavi, SH; Rahimi, VB | 1 |
| Askari, VR; Baradaran Rahimi, V; Mousavi, SH | 1 |
| Cai, H; Chen, X; Han, B; He, Z; Hu, Y; Kong, W; Kong, WJ; Li, Y; Sun, H; Yang, X; Yuan, J; Zhao, X | 1 |
| Anima, B; Gurusubramanian, G; Jeremy, M; Kharwar, RK; Pankaj, PP; Rempuia, V; Roy, VK | 1 |
| Chai, YR; Su, Q; Sun, Y; Yang, SP; Zhang, YR | 1 |
| Alvarez-Iglesias, A; Browne, M; Devane, D; Dunne, F; Gillespie, P; Newman, C; O'Donnell, M; Smyth, A | 1 |
| Abo-Elsoud, RAA; Ameen, O; Samaka, RM | 1 |
| Hu, Y; Liu, S; Song, Q; Yan, C | 1 |
| Hayes, GR; Jacobs, DB; Lockwood, DH; Truglia, JA | 1 |
| Cai, J; Hu, H; Huang, M; Li, Y; Song, J; Tian, N; Wang, Y; Wu, C; Xing, Q | 1 |
| Abdel-Rahman, RF; El-Gamil, MA; El-Ridy, MS; Elsayed, I; Yehia, SA; Younis, MM | 1 |
| Al-Shoubki, AA; Donia, AA; Mady, OY; Qasim, W | 1 |
| Al-Shoubki, AA; Donia, AA; Mady, OY | 1 |
1 trial(s) available for metformin and galactose
| Article | Year |
|---|---|
A randomised placebo-controlled trial of the effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (EMERGE): study protocol.
Topics: Blood Glucose; Clinical Trials, Phase III as Topic; Diabetes, Gestational; Female; Galactose; Gestational Weight Gain; Humans; Hypoglycemia; Infant, Newborn; Insulin; Metformin; Pregnancy; Quality of Life; Randomized Controlled Trials as Topic; Weight Gain | 2022 |
16 other study(ies) available for metformin and galactose
| Article | Year |
|---|---|
Pharmacodynamic-pharmacokinetic profiles of metformin hydrochloride from a mucoadhesive formulation of a polysaccharide with antidiabetic property in streptozotocin-induced diabetic rat models.
Topics: Adhesiveness; Animals; Blood Glucose; Chemistry, Pharmaceutical; Culture Techniques; Diabetes Mellitus, Experimental; Drug Compounding; Drug Delivery Systems; Excipients; Galactose; Hypoglycemic Agents; Intestinal Mucosa; Male; Metformin; Plant Gums; Rats; Rats, Wistar; Streptozocin; Tensile Strength; Tissue Adhesives; Treatment Outcome | 2004 |
Involvement of insulin resistance in D-galactose-induced age-related dementia in rats: Protective role of metformin and saxagliptin.
Topics: Adamantane; Aging; Animals; Biomarkers; Body Weight; Brain; Dementia; Dipeptides; Galactose; Glycated Hemoglobin; Hypoglycemic Agents; Insulin Resistance; Locomotion; Male; Metformin; Nerve Tissue Proteins; Oxidative Stress; Rats; Rats, Wistar; Reaction Time | 2017 |
d-galactose induces premature senescence of lens epithelial cells by disturbing autophagy flux and mitochondrial functions.
Topics: Adenosine Triphosphate; Antioxidants; Autophagy; Calcium Signaling; Cataract; Cell Line; Cell Proliferation; Cellular Senescence; Eye Proteins; Galactose; Gene Expression Regulation; Humans; Hypoglycemic Agents; Lens, Crystalline; Membrane Potential, Mitochondrial; Metformin; Mitochondria; Oxidative Stress; Reactive Oxygen Species | 2018 |
Metformin ameliorates the age-related changes of d-galactose administration in ovariectomized mice.
Topics: Aging; Animals; Anti-Inflammatory Agents; Antioxidants; Brain; Brain-Derived Neurotrophic Factor; Female; Galactose; Maze Learning; Metformin; Mice; Neuroprotective Agents; Ovariectomy; Superoxide Dismutase | 2018 |
Ellagic acid reveals promising anti-aging effects against d-galactose-induced aging on human neuroblastoma cell line, SH-SY5Y: A mechanistic study.
Topics: Aging; Anilides; beta-Galactosidase; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Ellagic Acid; Galactose; Glutathione; Glycation End Products, Advanced; Humans; Malondialdehyde; Mannitol; Metformin; Neuroblastoma; Protoporphyrins; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2018 |
Ellagic acid dose and time-dependently abrogates d-galactose-induced animal model of aging: Investigating the role of PPAR-γ.
Topics: Aging; Anilides; Animals; Apoptosis; Brain; Ellagic Acid; Galactose; Glutathione Peroxidase; Liver; Male; Malondialdehyde; Metformin; Mice; Models, Animal; Oxidative Stress; PPAR gamma; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2019 |
Metformin attenuates the D‑galactose‑induced aging process via the UPR through the AMPK/ERK1/2 signaling pathways.
Topics: Aging; AMP-Activated Protein Kinases; Animals; Antioxidants; Apoptosis; Auditory Cortex; Disease Models, Animal; Galactose; Male; MAP Kinase Signaling System; Metformin; Oxidative Stress; PC12 Cells; Presbycusis; Rats; Rats, Sprague-Dawley; Unfolded Protein Response | 2020 |
Effects of metformin on the uterus of d-galactose-induced aging mice: Histomorphometric, immunohistochemical localization (B-cell lymphoma 2, Bcl2-associated X protein, and active capase3), and oxidative stress study.
Topics: Aging; Animals; bcl-2-Associated X Protein; Caspase 3; Female; Galactose; Metformin; Mice; Oxidative Stress; Uterus | 2022 |
Metformin ameliorates thymus degeneration of mice by regulating mitochondrial function.
Topics: Aging; Animals; Cellular Senescence; Galactose; Metformin; Mice; Mitochondria; Thymus Gland | 2022 |
Metformin alleviates neurocognitive impairment in aging via activation of AMPK/BDNF/PI3K pathway.
Topics: Aging; AMP-Activated Protein Kinases; Animals; Brain-Derived Neurotrophic Factor; Caspase 3; Galactose; Male; Metformin; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-bcl-2; Rats; Saline Solution; Synaptophysin | 2022 |
[Metformin inhibits self-renewal of colorectal cancer stem cells by inhibiting mitochondrial oxidative phosphorylation].
Topics: Antibodies; Colorectal Neoplasms; Galactose; Humans; Metformin; Oxidative Phosphorylation; Reactive Oxygen Species | 2023 |
Effects of metformin on insulin receptor tyrosine kinase activity in rat adipocytes.
Topics: Adipose Tissue; Animals; Blood Glucose; Hexoses; Male; Metformin; Phosphorylation; Protein-Tyrosine Kinases; Rats; Rats, Inbred Strains; Receptor, Insulin | 1986 |
Improving oral bioavailability of metformin hydrochloride using water-in-oil microemulsions and analysis of phase behavior after dilution.
Topics: Administration, Oral; Animals; Biological Availability; Emulsions; Ethylene Glycols; Glycerides; Glycerol; Hexoses; Hypoglycemic Agents; Intestinal Absorption; Intestinal Mucosa; Linoleic Acids; Male; Metformin; Oleic Acids; Organic Chemicals; Phase Transition; Polysorbates; Rats, Sprague-Dawley; Solubility; Surface-Active Agents; Water | 2014 |
Metformin hydrochloride and wound healing: from nanoformulation to pharmacological evaluation.
Topics: Administration, Cutaneous; Animals; Blood Glucose; Cholesterol; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Compounding; Drug Liberation; Hexoses; Humans; Hypoglycemic Agents; Liposomes; Male; Metformin; Nanocapsules; Polysorbates; Rats, Wistar; Skin; Tissue Distribution; Wound Healing | 2019 |
Metformin hydrochloride entrapment in sorbitan monostearate for intestinal permeability enhancement and pharmacodynamics.
Topics: Animals; Cell Membrane Permeability; Excipients; Hexoses; Intestinal Mucosa; Male; Metformin; Rabbits; Surface-Active Agents | 2021 |
An Industrial Procedure for Pharmacodynamic Improvement of Metformin HCl via Granulation with Its Paracellular Pathway Enhancer Using Factorial Experimental Design.
Topics: Animals; Blood Glucose; Crystallization; Diabetes Mellitus, Experimental; Drug Compounding; Hexoses; Hypoglycemic Agents; Male; Metformin; Permeability; Polysorbates; Rabbits; Rats; Rats, Wistar; Surface-Active Agents | 2021 |